2019, Number S1
<< Back Next >>
Rev Mex Anest 2019; 42 (S1)
Evidence of cannabinoid use
Gaspar-Carrillo SP
Language: Spanish
References: 7
Page: 82-84
PDF size: 113.16 Kb.
Text Extraction
No abstract.
REFERENCES
Gatta-Cherifi B, Cota D. New insights on the role of the endocannabinoid system in the regulation of energy balance. Int J Obes. 2016;40:210-219.
Canadian Agency for Drugs and Technologies in Health. CADTH Peer Review Checklist for Search Strategies (Internet). Ottawa, Canada: CADTH; 2013. [Accessed March 17, 2014] https://www.cadth.ca/resources/finding-evidence/cadth-peer-review-checklist search-strategies.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, et al. Cannabinoids for medical use a systematic review and meta-analysis. JAMA. 2015;313(24):2456-2473.
Petzke F, Enax-Krumova EK, Häuser W. Wirksamkeit Verträglichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen. Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: a systematic review of randomized controlled studies. Schmerz. 2016;30(1):62-88.
Boychuk DG, Goddard G, Mauro G, et al. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. J Oral Facial Pain Headache. 2015;29(1):7-14.
Müller HH, Kornhuber J, Sperling W. The behavioral profile of spice and synthetic cannabinoids in humans. Brain Res Bull. 2016;
Cranford JA, Arnedt JT, Conroy DA, Bohnert KM, Bourque C, Blow FC, et al. Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain. Drug Alcohol Depend. 2017;180:227-233.126:3-7.
Full text